Cyncron (previously Medicon) is a full service phase I-IV drug development company offering in-house expertise in clinical operations, clinical pharmacology, biometrics, medical affairs, pharmacovigilance, quality management and consultancy services.
Cyncron was founded in 1985 with the aim of improving the quality, efficacy and safety of clinical trials, through optimisation of clinical trial organisation and management. These aims continue to be our principle focus.
In the early days, Cyncron focused primarily on large, multicenter phase III trials in the cardiovascular field in Scandinavia.
Today Cyncron has offices in Denmark, Sweden and Finland and operates in the nordic countries. Through partnership Cyncron also satisfies request for services in other countries.
Cyncron serves national and international clients ranging from large pharmaceutical to smaller biotech companies in practically all therapeutic fields. Cyncron has an outstanding track record in clinical research and strong liaisons in academia and the biotech and pharmaceutical industry.
Cyncron plans and conducts clinical trials at state of the art quality in the most cost- and time efficient ways securing that the investigated patient sample is a true reflection of the market of the future drug thus providing value by improving the conclusiveness of the trials.
CRO Services
Our services in clinical development include:
· Clinical Operations >
· Biometrics >
· Data Monitoring Committee >
· Medical Affairs >
· Quality Management >
